Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Settings
Language
ENGLISH
Currency
USD
Theme
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rank in Stocks #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Share Price
$4.84
Market Cap
$633.18M
Change (1 day)
3.20%
Change (1 year)
0.00%
Country
GB
Trade Exscientia plc (EXAI)

Category

Healthcare
Number of shares outstanding for Exscientia plc (EXAI)
Number of shares outstanding as of September 2024: 126.59M
According to Exscientia plc latest financial reports and stock price the company's current number of shares outstanding is 126.59M. At the end of December 2022 the company had 122.12M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Exscientia plc (EXAI) from 2019 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 126.59M 1.93%
2023 124.20M 1.70%
2022 122.12M 1.02%
2021 120.89M 0.41%
2020 120.39M 0.00%
2019 120.39M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 3,413.46%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 100.56%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M -18.72%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 50.08%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 281.99%
AU